Filing Flows › 60 Degrees Pharmaceuticals (SXTP) › Recalls, complaints & regulation
60 Degrees Pharmaceuticals (SXTP): clinical trials
60 Degrees Pharmaceuticals (SXTP) beyond its filings: 2 active clinical trials.
60 Degrees Pharmaceuticals' latest quarter
60 Degrees Pharmaceuticals, Q2 2026: revenue $208K (+106% year over year), net loss $2.3M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does 60 Degrees Pharmaceuticals have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.